DaVita HealthCare Partners Inc (DVA) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
Total Assets Chart for DaVita HealthCare Partners Inc
DaVita HealthCare Partners Inc (DVA) total assets for FY2025 were USD 17.5B, a 1.1% change from FY2024. DaVita HealthCare Partners Inc's total assets grew from USD 77.6M in 1994 to USD 17.5B in 2025 (22425.9% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 0.6%, 10-year CAGR of -0.6%, 20-year CAGR of 5.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $11.60B
- Implied Share Price
- $180.67
- Enterprise Value
- $27.35B
- Revenue (TTM)
- $14.01B
- EBITDA
- $2.83B
- Profit Margin
- 6.05%
- Trailing P/E
- 16.00
- Forward P/E
- 15.72
- Price/Book (MRQ)
- 91.65
- Price/Sales (TTM)
- 0.82
- EV/EBITDA
- 9.87
- EV/Revenue
- 1.95
- Dividend Yield
- —
- Book Value
- $-11.41
- Free Cash Flow (FY2025)
- $1.31B
- Free Cash Flow Yield
- 11.30%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.